GlassScriptPhysician profile
Dennis C Eckel
NPI 1972565695
$1,881.41
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $306 · 2021: $590 · 2022: $391 · 2023: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.88 | 2020-2023 | Lo Loestrin Fe |
| Therapeuticsmd, INC. | $194.12 | 2019-2021 | |
| Organon LLC | $174.53 | 2021-2023 | Nexplanon |
| Amgen INC. | $135.48 | 2019-2023 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $119.65 | 2019-2021 | |
| Exeltis, USA INC. | $117.79 | 2020-2023 | Slynd |
| Mayne Pharma Commercial LLC | $110.52 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $107.93 | 2019-2023 | |
| Hologic Sales and Service, LLC | $80.76 | 2019-2023 | Thinprep 2000 Processor |
| Coopersurgical, INC. | $80.13 | 2019-2022 | |
| Boston Scientific Corporation | $61.95 | 2019-2022 | |
| Avion Pharmaceuticals | $57.22 | 2020-2023 | Balcoltra |
| Millicent US INC | $50.76 | 2020-2021 | |
| Pfizer INC. | $48.95 | 2020-2021 | |
| Daiichi Sankyo INC. | $37.44 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $32.79 | 2019-2021 | |
| Exact Sciences Corporation | $24.88 | 2023 | Cologuard Collection Kit |
| Roche Diagnostics Corporation | $24.45 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.93 | 2019 | |
| Ethicon US, LLC | $20.96 | 2019 | |
| Minerva Surgical, INC | $19.82 | 2019 | |
| Becton, Dickinson and Company | $16.08 | 2021 | |
| Sage Therapeutics, LLC | $15.83 | 2022 | |
| Agile Therapeutics, INC. | $15.26 | 2023 | Twirla |
| Forte Bio-Pharma LLC | $13.11 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.82 | 2020 | |
| Shield Therapeutics INC | $12.79 | 2022 | |
| Duchesnay USA Incorporated | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Eckel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.